Bangkok, Thailand, August 30, 2017 - A study by DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business in Asia, revealed that almost twice as many healthcare decision makers in Asia plan to increase (36%) versus decrease (20%) the outsourcing of commercial activities to a third party in the coming twelve months.

Commercial outsourcing is defined as the contracting of sales, marketing and other commercial services from an external partner for some or all of the organization's product portfolios. 68% of the respondents from brand owning companies consider working with a company like DKSH to expand into new Asian markets. Among companies new to Asia, this is 76%, versus 64% among the well-established companies in Asia.

Although three out of four (78%) of the respondents rate their company's performance in 2016 as either good, very good or excellent, challenges for growth remain. Decision makers state the increased need for market insights, return on investments and sales force effectiveness as key challenges.

"General managers of healthcare companies are playing catch-up in a fast-changing Asian environment and are pressured to do more with less. More than ever, they need to assess their companies' core strengths, determine which areas they need to focus their resources on, and where they would be better served leveraging a strategic business partner. Therefore, at DKSH we continue to invest in training our dedicated healthcare salesforce - with 4,200 specialists the largest in Asia - as well as in our team of 70 regulatory experts," said Bijay Singh, Head, Business Unit Healthcare.

To be considered in the first place, commercial outsourcing partners need to demonstrate market understanding and sales capabilities. Commercial services most considered for outsourcing are in-field execution of sales and promotions, consignment inventory management and merchandising.

Singh added: "Beyond these direct needs, clients tell us in the research that people make the difference in the relationship; how they communicate, demonstrate understanding of the business and act in a compliant manner. Proper alliance management on both sides is key, as are regular business reviews, clear targets and reporting and joint problem-solving where appropriate."

The "Growth in Asia: to make or to buy?" research was conducted between April and July 2017 by Be Digital, a Bangkok-based research company. The research consisted of an online survey and phone interviews among 90 of the total 4,000 healthcare decision makers in DKSH's database in Asia, mostly with regional responsibilities.

About DKSH

DKSH is the leading Market Expansion Services provider with a focus on Asia. As the term "Market Expansion Services" suggests, DKSH helps other companies and brands to grow their business in new or existing markets. Publicly listed on the SIX Swiss Exchange since 2012, DKSH is a global company headquartered in Zurich. With 780 business locations in 36 countries - 750 of them in Asia - and 30,320 specialized staff, DKSH generated net sales of CHF 10.5 billion in 2016. DKSH was founded in 1865. With strong Swiss heritage, the company has a long tradition of doing business in and with Asia and is deeply rooted in communities and businesses across Asia Pacific.

DKSH Business Unit Healthcare is the leading Market Expansion Services provider for healthcare companies seeking to grow their business in Asia. Custom-made offerings comprise registration, regulatory services, market entry studies, importation, customs clearance, marketing and sales, capillary physical distribution, invoicing and cash collection. Products available through DKSH Healthcare include pharmaceuticals, consumer health and over-the-counter (OTC) products as well as medical devices. With 120 business locations in 13 countries and around 9,740 specialized staff, Business Unit Healthcare serves over 150,000 customers and generated net sales of CHF 5.5 billion in 2016.

For further information please contact:

DKSH Healthcare

Kalle Siebring

Manager, Group Communications

Business Unit Consumer Goods and Healthcare

Phone +66 2 220 9739

kalle.siebring@dksh.com

DKSH Holding AG published this content on 30 August 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 31 August 2017 07:47:05 UTC.

Original documenthttp://www.dksh.com/global-en/home/media/news?id=tag:xml.newsbox.ch,2017-08-30:1101.677.digest

Public permalinkhttp://www.publicnow.com/view/D3BD07C7B79FC86175B0CD03C5FDFDAC1BE7F2B1